Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials

This publication has 26 references indexed in Scilit:

• Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial
  The Lancet, 2006
• Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial
  European Heart Journal, 2005
• Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion ? results of the Austrian multi-centre randomized ReoPro-BRIDGING Study
  European Heart Journal, 2004
• ?Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial
  Published by Oxford University Press (OUP) ,2004
• Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction
  The American Journal of Cardiology, 2003
• Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes
  Circulation, 2003
• P2853 Early administration of abciximab bolus in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by TIMI Frame Count: results of the ERAMI trial
  Published by Elsevier ,2003
• P1502 Prehospital versus periprocedural administration of abciximab in STEMI: early and late results from the randomised REOMOBILE-study
  Published by Elsevier ,2003
• Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty
  The American Journal of Cardiology, 2002
• High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial
  Journal of the American College of Cardiology, 2000